Design, Synthesis,and Molecular Docking Studies ofNovel Pyrazoline-Thiazoles as Cholinesterase Dual-Target Inhibitorsfor the Treatment of Alzheimer’s Disease. This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.